K V Gopalakrishna

1.1k total citations
24 papers, 745 citations indexed

About

K V Gopalakrishna is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, K V Gopalakrishna has authored 24 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Infectious Diseases and 6 papers in Surgery. Recurrent topics in K V Gopalakrishna's work include Streptococcal Infections and Treatments (6 papers), Infective Endocarditis Diagnosis and Management (4 papers) and Antifungal resistance and susceptibility (2 papers). K V Gopalakrishna is often cited by papers focused on Streptococcal Infections and Treatments (6 papers), Infective Endocarditis Diagnosis and Management (4 papers) and Antifungal resistance and susceptibility (2 papers). K V Gopalakrishna collaborates with scholars based in United States and Jordan. K V Gopalakrishna's co-authors include Phillip I. Lerner, Emanuel Wolinsky, David M. Shlaes, Robert A. Salata, Martin C. McHenry, James S. Tan, Fahrettin Covut, Tariq Kewan, Mohammed Al‐Jaghbeer and Michael M. Lederman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Industrial & Engineering Chemistry Research.

In The Last Decade

K V Gopalakrishna

23 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K V Gopalakrishna United States	12	355	280	271	107	98	24	745
Lurdes Santos Portugal	14	143 0.4×	211 0.8×	218 0.8×	101 0.9×	47 0.5×	74	651
Paula Yocum United States	15	286 0.8×	202 0.7×	325 1.2×	122 1.1×	17 0.2×	16	725
Joshua Osowicki Australia	14	273 0.8×	155 0.6×	258 1.0×	62 0.6×	15 0.2×	58	511
Kensuke Shoji Japan	16	76 0.2×	377 1.3×	352 1.3×	100 0.9×	47 0.5×	109	824
É. Rouveix France	15	106 0.3×	458 1.6×	464 1.7×	78 0.7×	28 0.3×	77	948
Gabriel M. Aisenberg United States	8	83 0.2×	128 0.5×	341 1.3×	73 0.7×	132 1.3×	32	687
Seong‐Ho Choi South Korea	17	99 0.3×	271 1.0×	319 1.2×	257 2.4×	67 0.7×	58	908
Mike Starr Australia	14	97 0.3×	390 1.4×	237 0.9×	58 0.5×	20 0.2×	36	609
David Seal United Kingdom	22	549 1.5×	171 0.6×	217 0.8×	53 0.5×	27 0.3×	38	1.4k
Galo Peralta Spain	12	152 0.4×	251 0.9×	152 0.6×	223 2.1×	16 0.2×	24	767

Countries citing papers authored by K V Gopalakrishna

Since Specialization

Citations

This map shows the geographic impact of K V Gopalakrishna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K V Gopalakrishna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K V Gopalakrishna more than expected).

Fields of papers citing papers by K V Gopalakrishna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K V Gopalakrishna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K V Gopalakrishna. The network helps show where K V Gopalakrishna may publish in the future.

Co-authorship network of co-authors of K V Gopalakrishna

This figure shows the co-authorship network connecting the top 25 collaborators of K V Gopalakrishna. A scholar is included among the top collaborators of K V Gopalakrishna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K V Gopalakrishna. K V Gopalakrishna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

García-Fuentes, Marcos & K V Gopalakrishna. (2023). A Case of Imported Leptospirosis: Rhabdomyolysis and Severe Hyperbilirubinemia in a Traveler Returning From Puerto Rico. Cureus. 15(2). e34690–e34690. 2 indexed citations

Alomari, Mohammad, et al.. (2020). Improving Physician-patient and Physician-nurse Communication and Overall Satisfaction Rates: A Quality Improvement Project. Cureus. 12(4). e7776–e7776. 15 indexed citations

Lak, Hassan Mehmood, et al.. (2020). Reducing All-cause 30-day Hospital Readmissions for Patients Presenting with Acute Heart Failure Exacerbations: A Quality Improvement Initiative. Cureus. 12(3). e7420–e7420. 26 indexed citations

Gopalakrishna, K V, et al.. (2020). Early Use of Tocilizumab May Prevent Clinical Deterioration in Select COVID-19 Patients: A Case Series. Cureus. 12(7). e9187–e9187. 1 indexed citations

Kewan, Tariq, et al.. (2020). Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study. EClinicalMedicine. 24. 100418–100418. 128 indexed citations

Dermawan, Josephine Kam Tai, Subha Ghosh, M. Kelly Keating, K V Gopalakrishna, & Sanjay Mukhopadhyay. (2018). Candida pneumonia with severe clinical course, recovery with antifungal therapy and unusual pathologic findings. Medicine. 97(2). e9650–e9650. 13 indexed citations

Lokhande, Chetan, et al.. (2015). Paraganglioma Presenting as Postpartum Fever of Unknown Origin. Case Reports in Endocrinology. 2015. 1–4. 3 indexed citations

Karivedu, Vidhya, et al.. (2015). A Case of Typhoid Fever with Hepatic Granulomas and Enteritis. SHILAP Revista de lepidopterología. 2015. 1–3. 7 indexed citations

Kawsar, Hameem I., et al.. (2012). Hepatitis B reactivation in cancer patients: role of prechemotherapy screening and antiviral prophylaxis.. PubMed. 10(6). 370–8. 18 indexed citations

10.

Kawsar, Hameem I. & K V Gopalakrishna. (2012). Spinal Tuberculosis. Infectious Diseases in Clinical Practice. 21(3). 192–195.

11.

Taylor, Harris C., et al.. (2011). Bacteriologic Assessment of Reused Metered Dose Inhalers. Infectious Diseases in Clinical Practice. 19(4). 265–267. 3 indexed citations

12.

Gopalakrishna, K V, et al.. (2010). Lactobacillus-Cause of Death. Infectious Diseases in Clinical Practice. 18(3). 219–220. 1 indexed citations

13.

McComsey, Grace A., Christopher C. Whalen, Steven D. Mawhorter, et al.. (2001). Placebo-controlled trial of prednisone in advanced HIV-1 infection. AIDS. 15(3). 321–327. 65 indexed citations

14.

Gopalakrishna, K V, et al.. (1995). Oxidation of Sulfur Dioxide in Aqueous Suspensions of Activated Carbon. Industrial & Engineering Chemistry Research. 34(7). 2258–2271. 10 indexed citations

15.

Rosenkranz, Peter, Michael M. Lederman, K V Gopalakrishna, & Jerrold J. Ellner. (1990). Septic Arthritis Caused by Bacteroides fragilis. Clinical Infectious Diseases. 12(1). 20–30. 19 indexed citations

16.

Salata, Robert A., Phillip I. Lerner, David M. Shlaes, K V Gopalakrishna, & Emanuel Wolinsky. (1989). Infections Due to Lancefield Group C Streptococci. Medicine. 68(4). 225–239. 149 indexed citations

17.

Shlaes, David M., Phillip I. Lerner, Emanuel Wolinsky, & K V Gopalakrishna. (1981). Infections Due to Lancefield Group F and Related Streptococci (S. milleri, S. anginosus). Medicine. 60(3). 197–207. 89 indexed citations

18.

Lerner, Phillip I., et al.. (1977). GROUP B STREPTOCOCCUS (S. AGALACTIAE) BACTEREMIA IN ADULTS. Medicine. 56(6). 457–474. 145 indexed citations

19.

Gopalakrishna, K V, et al.. (1977). Metastatic myocardial abscess due to group F streptococci. The American Journal of the Medical Sciences. 274(3). 329–332. 10 indexed citations

20.

Gopalakrishna, K V & Phillip I. Lerner. (1973). Tetracycline-resistant pneumococci: increasing incidence and cross resistance to newer tetracyclines.. PubMed. 108(4). 1007–10. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact